biota tripled ,invested 1/2 in sirtex = SRX which will be having a nice run coming up. Sirtex to be showcased in upcoming US coferences and appearing with Pfizer, Sanofi-Aventis and Genentech which are 110 billion USD market cap companies. Big thing is that small 78 million USD market cap Sirtex has FDA approved Sir Spheres which work synergistically with all of these companies chemotherapy drugs for many different cancers that metastasize to the liver and for liver cancer. Believe alot of Biota profits from other investors will be heading towards the Sirtex share after share is past 2.55 for run to 3.70-4.60. short term. One of many links is
http://www.cancerconferences.com/
See the 4th International Congress
or
http://www.touchbriefings.com/pdf/1432/Kennedy.pdf
which will be circulated from European to American medical journals.
2% market share, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)